newsfilter
← Latest News
GlobeNewswire·

Glucotrack Announces USPTO Notice of Allowance for Patent Application Covering Its Implantable CBGM Platform

RUTHERFORD, N.J., July 08, 2026 (GLOBE NEWSWIRE) -- Glucotrack, Inc. ("Glucotrack", or the "Company") (NASDAQ:GCTK), a medical technology company focused on the design, development, and